183 related articles for article (PubMed ID: 18053981)
21. Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice.
Kraeuter AK; Mashavave T; Suvarna A; van den Buuse M; Sarnyai Z
Psychopharmacology (Berl); 2020 May; 237(5):1397-1405. PubMed ID: 31993694
[TBL] [Abstract][Full Text] [Related]
22. Critical involvement of the orbitofrontal cortex in hyperlocomotion induced by NMDA receptor blockade in mice.
Seiriki K; Kasai A; Kuwaki T; Nakazawa T; Yamaguchi S; Hashimoto H
Biochem Biophys Res Commun; 2016 Nov; 480(4):558-563. PubMed ID: 27793672
[TBL] [Abstract][Full Text] [Related]
23. NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.
Kim HS; Rhee GS; Oh S; Park WK
Behav Brain Res; 1999 Apr; 100(1-2):135-42. PubMed ID: 10212060
[TBL] [Abstract][Full Text] [Related]
24. Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus.
Al-Amin HA; Weinberger DR; Lipska BK
Behav Pharmacol; 2000 Jun; 11(3-4):269-78. PubMed ID: 11103881
[TBL] [Abstract][Full Text] [Related]
25. The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex.
Castañé A; Artigas F; Bortolozzi A
Psychopharmacology (Berl); 2008 Oct; 200(2):281-90. PubMed ID: 18594799
[TBL] [Abstract][Full Text] [Related]
26. Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
Hesselink MB; Smolders H; De Boer AG; Breimer DD; Danysz W
Behav Pharmacol; 1999 Feb; 10(1):85-98. PubMed ID: 10780305
[TBL] [Abstract][Full Text] [Related]
27. MK-801 potentiates ethanol's effects on locomotor activity in mice.
Shen EH; Phillips TJ
Pharmacol Biochem Behav; 1998 Jan; 59(1):135-43. PubMed ID: 9443548
[TBL] [Abstract][Full Text] [Related]
28. The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.
Ma J; Leung LS
Psychopharmacology (Berl); 2007 May; 191(4):961-74. PubMed ID: 17219218
[TBL] [Abstract][Full Text] [Related]
29. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice.
Scorza MC; Castañé A; Bortolozzi A; Artigas F
Neuropharmacology; 2010; 59(1-2):112-20. PubMed ID: 20412811
[TBL] [Abstract][Full Text] [Related]
30. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion.
Ninan I; Kulkarni SK
Eur J Pharmacol; 1998 Oct; 358(2):111-6. PubMed ID: 9808259
[TBL] [Abstract][Full Text] [Related]
31. Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice.
Zhou X; Chen Q; Hu X; Mao S; Kong Y
Behav Brain Res; 2014 Jan; 258():153-9. PubMed ID: 24149067
[TBL] [Abstract][Full Text] [Related]
32. Effects of the NMDA receptor antagonist MK-801 on short-interval timing in rats.
Miller JP; McAuley JD; Pang KC
Behav Neurosci; 2006 Feb; 120(1):162-72. PubMed ID: 16492126
[TBL] [Abstract][Full Text] [Related]
33. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
Okuyama S; Imagawa Y; Tomisawa K
Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
[TBL] [Abstract][Full Text] [Related]
34. NMDA antagonists block expression of sensitization of amphetamine- and apomorphine-induced stereotypy.
Battisti JJ; Shreffler CB; Uretsky NJ; Wallace LJ
Pharmacol Biochem Behav; 2000 Oct; 67(2):241-6. PubMed ID: 11124387
[TBL] [Abstract][Full Text] [Related]
35. Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice.
Chen PA; Wang HY; Sun CL; Chen ML; Chen YC
Behav Neurol; 2022; 2022():1048463. PubMed ID: 35251367
[TBL] [Abstract][Full Text] [Related]
36. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
[TBL] [Abstract][Full Text] [Related]
37. NMDA receptor-dependent and -independent behavioural sensitization.
Tagliamonte A; Gambarana C; De Montis MG
Trends Pharmacol Sci; 1999 May; 20(5):187-8; author reply 189-90. PubMed ID: 10354610
[No Abstract] [Full Text] [Related]
38. Glycine and D-serine decrease MK-801-induced hyperactivity in mice.
Nilsson M; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1997; 104(11-12):1195-205. PubMed ID: 9503265
[TBL] [Abstract][Full Text] [Related]
39. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.
Mastropaolo J; Rosse RB; Deutsch SI
Behav Brain Res; 2004 Aug; 153(2):419-22. PubMed ID: 15265637
[TBL] [Abstract][Full Text] [Related]
40. Adult and adolescent C57BL/6J and DBA/2J mice are differentially susceptible to fear learning deficits after acute ethanol or MK-801 treatment.
Seemiller LR; Gould TJ
Behav Brain Res; 2021 Jul; 410():113351. PubMed ID: 33974921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
